Sector Chart Actinium Pharmaceuticals, Inc.
Stocks
ATNM
US00507W2061
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 1.050 USD | +5.00% |
|
+5.00% | -22.79% |
| 08-14 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-14 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 33.01M | - | - | - | ||
| 69.02B | |||||
| 66.32B | |||||
| 27.66B | - | ||||
| 25.84B | - | ||||
| 26.54B |
Select your edition
All financial news and data tailored to specific country editions
